<DOC>
	<DOCNO>NCT00018148</DOCNO>
	<brief_summary>Treatment smoker tricyclic antidepressant , nortriptyline , reduce tobacco withdrawal symptom increase long term cessation rate combine transdermal nicotine behavioral cessation program . The study placebo-controlled , randomize , parallel group trial smoker age 18-70 subject combination oral patch treatment .</brief_summary>
	<brief_title>Combined Nortriptyline Transdermal Nicotine Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<criteria>Aged 1870 , smoke &gt; 10 cigarette per day , current major depression , concurrent psychiatric medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>smoke cessation</keyword>
</DOC>